| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.026 | 0.8 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |